Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:11555654rdf:typepubmed:Citationlld:pubmed
pubmed-article:11555654lifeskim:mentionsumls-concept:C0023418lld:lifeskim
pubmed-article:11555654lifeskim:mentionsumls-concept:C0007634lld:lifeskim
pubmed-article:11555654lifeskim:mentionsumls-concept:C0007589lld:lifeskim
pubmed-article:11555654lifeskim:mentionsumls-concept:C0040845lld:lifeskim
pubmed-article:11555654lifeskim:mentionsumls-concept:C0065088lld:lifeskim
pubmed-article:11555654lifeskim:mentionsumls-concept:C0021467lld:lifeskim
pubmed-article:11555654lifeskim:mentionsumls-concept:C1622946lld:lifeskim
pubmed-article:11555654lifeskim:mentionsumls-concept:C0021469lld:lifeskim
pubmed-article:11555654lifeskim:mentionsumls-concept:C1511938lld:lifeskim
pubmed-article:11555654pubmed:issue46lld:pubmed
pubmed-article:11555654pubmed:dateCreated2001-11-12lld:pubmed
pubmed-article:11555654pubmed:abstractTextLithium affects several enzymatic activities, however, the molecular mechanisms of lithium actions are not fully understood. We previously showed that LiCl interacts synergistically with all-trans-retinoic acid to promote terminal differentiation of WEHI-3B D(+) cells, a phenomenon accompanied by the recovery of the retinoid-induced loss of retinoic acid receptor alpha protein pools. Here, we demonstrate the effects of LiCl on proteasome-dependent degradation of retinoic acid receptor alpha proteins. LiCl alone, or in combination with all-trans-retinoic acid, increased cellular levels of ubiquitinated retinoic acid receptor alpha and markedly reduced chymotryptic-like activity of WEHI-3B D(+) 20 S and 26 S proteasome enzymes. Neither KCl nor all-trans-retinoic acid affected enzyme activity, whereas NaCl produced a modest reduction at relatively high concentrations. In addition, LiCl inhibited 20 S proteasome chymotryptic-like activity from rabbits but had no effect on tryptic-like activity of the 26 S proteasome. This effect has significant consequences in stabilizing the retinoic acid receptor alpha protein levels that are necessary to promote continued differentiation of leukemia cells in response to all-trans-retinoic acid. In support of this concept, combination of proteasome inhibitors beta-clastolactacystin or benzyloxycarbonyl-Leu-Leu-Phe with all-trans-retinoic acid increased differentiation of WEHI-3B D(+) cells in a manner that was analogous to the combination of LiCl and all-trans-retinoic acid.lld:pubmed
pubmed-article:11555654pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11555654pubmed:languageenglld:pubmed
pubmed-article:11555654pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11555654pubmed:citationSubsetIMlld:pubmed
pubmed-article:11555654pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11555654pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11555654pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11555654pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11555654pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11555654pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11555654pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11555654pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11555654pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11555654pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11555654pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11555654pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11555654pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11555654pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11555654pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11555654pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11555654pubmed:statusMEDLINElld:pubmed
pubmed-article:11555654pubmed:monthNovlld:pubmed
pubmed-article:11555654pubmed:issn0021-9258lld:pubmed
pubmed-article:11555654pubmed:authorpubmed-author:SartorelliA...lld:pubmed
pubmed-article:11555654pubmed:authorpubmed-author:RiceA MAMlld:pubmed
pubmed-article:11555654pubmed:issnTypePrintlld:pubmed
pubmed-article:11555654pubmed:day16lld:pubmed
pubmed-article:11555654pubmed:volume276lld:pubmed
pubmed-article:11555654pubmed:ownerNLMlld:pubmed
pubmed-article:11555654pubmed:authorsCompleteYlld:pubmed
pubmed-article:11555654pubmed:pagination42722-7lld:pubmed
pubmed-article:11555654pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:11555654pubmed:meshHeadingpubmed-meshheading:11555654...lld:pubmed
pubmed-article:11555654pubmed:meshHeadingpubmed-meshheading:11555654...lld:pubmed
pubmed-article:11555654pubmed:meshHeadingpubmed-meshheading:11555654...lld:pubmed
pubmed-article:11555654pubmed:meshHeadingpubmed-meshheading:11555654...lld:pubmed
pubmed-article:11555654pubmed:meshHeadingpubmed-meshheading:11555654...lld:pubmed
pubmed-article:11555654pubmed:meshHeadingpubmed-meshheading:11555654...lld:pubmed
pubmed-article:11555654pubmed:meshHeadingpubmed-meshheading:11555654...lld:pubmed
pubmed-article:11555654pubmed:meshHeadingpubmed-meshheading:11555654...lld:pubmed
pubmed-article:11555654pubmed:meshHeadingpubmed-meshheading:11555654...lld:pubmed
pubmed-article:11555654pubmed:meshHeadingpubmed-meshheading:11555654...lld:pubmed
pubmed-article:11555654pubmed:meshHeadingpubmed-meshheading:11555654...lld:pubmed
pubmed-article:11555654pubmed:meshHeadingpubmed-meshheading:11555654...lld:pubmed
pubmed-article:11555654pubmed:meshHeadingpubmed-meshheading:11555654...lld:pubmed
pubmed-article:11555654pubmed:meshHeadingpubmed-meshheading:11555654...lld:pubmed
pubmed-article:11555654pubmed:meshHeadingpubmed-meshheading:11555654...lld:pubmed
pubmed-article:11555654pubmed:meshHeadingpubmed-meshheading:11555654...lld:pubmed
pubmed-article:11555654pubmed:meshHeadingpubmed-meshheading:11555654...lld:pubmed
pubmed-article:11555654pubmed:meshHeadingpubmed-meshheading:11555654...lld:pubmed
pubmed-article:11555654pubmed:meshHeadingpubmed-meshheading:11555654...lld:pubmed
pubmed-article:11555654pubmed:meshHeadingpubmed-meshheading:11555654...lld:pubmed
pubmed-article:11555654pubmed:meshHeadingpubmed-meshheading:11555654...lld:pubmed
pubmed-article:11555654pubmed:meshHeadingpubmed-meshheading:11555654...lld:pubmed
pubmed-article:11555654pubmed:meshHeadingpubmed-meshheading:11555654...lld:pubmed
pubmed-article:11555654pubmed:meshHeadingpubmed-meshheading:11555654...lld:pubmed
pubmed-article:11555654pubmed:meshHeadingpubmed-meshheading:11555654...lld:pubmed
pubmed-article:11555654pubmed:meshHeadingpubmed-meshheading:11555654...lld:pubmed
pubmed-article:11555654pubmed:year2001lld:pubmed
pubmed-article:11555654pubmed:articleTitleInhibition of 20 S and 26 S proteasome activity by lithium chloride: impact on the differentiation of leukemia cells by all-trans retinoic acid.lld:pubmed
pubmed-article:11555654pubmed:affiliationDepartment of Pharmacology and Developmental Therapeutics Program, Cancer Center, Yale University School of Medicine, New Haven, Connecticut 06520, USA.lld:pubmed
pubmed-article:11555654pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:11555654pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11555654lld:pubmed